Top compounds associated with response to TLL2


Feature Type Standardized
Nominal ANOVA
mRNA RO-3306 GDSC1000 pan-cancer AAC 0.043 0.2
mRNA SCH-529074 CTRPv2 pan-cancer AAC 0.051 0.2
mRNA WZ3105 GDSC1000 pan-cancer AAC 0.037 0.2
mRNA Imatinib GDSC1000 pan-cancer AAC -0.065 0.2
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.048 0.2
mRNA Gemcitabine gCSI pan-cancer AAC -0.074 0.2
mRNA NSC 74859 CTRPv2 pan-cancer AAC 0.05 0.2
mRNA LY317615 GDSC1000 pan-cancer AAC -0.041 0.2
mRNA RDEA119 GDSC1000 pan-cancer AAC -0.037 0.2
mRNA AS601245 GDSC1000 pan-cancer AAC -0.043 0.2
Download CSV